IMMUNOME, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.28 USD | +0.99% |
|
-17.00% | +24.11% |
| 05-31 | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
| 05-21 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
Chart calendar Immunome, Inc.
0cd5887b8106.60fuIkCXk3eeRp-8PFSmzCe8SDyathvmHG9cAW1Ivp8.0iGgdDej1RvELvn-cmOSlh_zLlvr6UuTVycwZisy1-yxDJ9SKfnDBu4D0g~8602f072145708380e46677dae01e2b1
Upcoming events on Immunome, Inc.
Past events on Immunome, Inc.
| 11/06/2024 | Annual General Meeting |
| 15/05/2024 18:40 | BofA Securities Health Care Conference |
| 14/05/2024 13:00 | Q1 2024 Earnings Release |
| 09/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract No: 6026 |
| 28/03/2024 20:02 | Q4 2023 Earnings Release |
| 12/03/2024 20:20 | Leerink Partners Global Biopharma Conference |
| 05/03/2024 17:50 | TD Cowen Health Care Conference - Panel |
| 08/02/2024 14:30 | Guggenheim Healthcare Talks Biotechnology Conference |
| 11/01/2024 15:30 | JPMorgan Healthcare Conference |
| 15/11/2023 20:00 | Stifel Healthcare Conference |
| 09/11/2023 13:00 | Q3 2023 Earnings Release |
| 28/09/2023 | Extraordinary Shareholders Meeting - M&A Vote |
| 09/08/2023 13:00 | Q2 2023 Earnings Release |
| 07/06/2023 18:00 | Annual General Meeting |
| 05/05/2023 13:00 | Q1 2023 Earnings Release |
| 16/03/2023 12:00 | Q4 2022 Earnings Release |
| 15/03/2023 11:00 | World ADC London conference |
| 14/11/2022 13:00 | Q3 2022 Earnings Release |
| 10/11/2022 14:00 | SITC Meeting - Abstract Number: 823 |
| 05/08/2022 13:00 | Interim 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 2,10 - | 0,00 0,00 - | 0,00 0,00 - | 14,0 12,3 14.3% | 7,03 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -212 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -12,3 -11,3 -8.81% | -25,2 -27,5 8.27% | -36,9 -38,0 2.92% | -28,7 -29,3 1.96% | -215 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -17,8 -16,8 -5.9% | 0,00 0,00 - | -36,9 -38,0 2.92% | -107 -30,7 -247.93% | -209 |
|
Net income Million USD | Released Forecast Spread | -10,4 | -17,8 -16,8 -5.9% | -24,7 -27,0 8.38% | -37,5 -38,0 1.28% | -107 -27,6 -286.53% | -201 |
|
EPS USD | Released Forecast Spread | -0,32 | -5,26 -8,63 39.05% | -2,14 -2,32 7.76% | -3,09 -3,08 -0.49% | -5,38 -0,97 -454.64% | -3,70 |
| Announcement Date | 09/09/20 | 25/03/21 | 28/03/22 | 16/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 2,36 0,00 - | 3,83 2,07 85.13% | 1,03 2,80 -63.25% | 1,87 | 1,87 | 2,23 | 0,00 | 0,00 | ||
|
EBIT Million USD | Released Forecast Spread | -11,7 -8,78 -32.76% | -8,93 -10,8 17.67% | -8,53 -9,31 8.32% | -7,79 -8,90 12.46% | -4,47 -7,43 39.85% | -13,9 -10,4 -33.11% | -132 -27,0 -389.39% | -26,0 | -27,5 | -29,3 | -29,8 | -32,0 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,53 -9,31 8.33% | -7,79 -8,90 12.47% | -4,27 -7,43 42.55% | -92,6 -12,6 -638.03% | -129 -26,3 -392.78% | -24,1 | -25,7 | -29,7 | -28,4 | -29,6 | ||||
|
Net income Million USD | Released Forecast Spread | -11,7 -8,66 -34.64% | -8,92 -10,7 16.75% | -9,16 -9,31 1.64% | -7,79 -8,90 12.47% | -4,27 -7,43 42.55% | -4,35 | -92,6 -12,0 -674.04% | -129 -39,2 -229.98% | -21,7 | -23,4 | -26,8 | -28,4 | -29,6 | |
|
EPS USD | Released Forecast Spread | -0,96 -0,69 -39.13% | -0,74 -0,93 20.43% | -0,75 -0,79 4.46% | -0,64 -0,68 5.19% | -0,35 0,59 -159.83% | -0,46 -0,16 -187.5% | -0,36 | -4,22 -0,28 -1389.43% | -2,51 -0,69 -261.67% | -0,39 | -0,42 | -0,47 | -0,59 | -0,61 |
| Announcement Date | 12/05/22 | 05/08/22 | 14/11/22 | 16/03/23 | 05/05/23 | 09/08/23 | 09/11/23 | 28/03/24 | 14/05/24 | - | - | - | - | - |
More events
Past sector events for Immunome, Inc.
| 05/06/2024 08:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 15/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMNM Stock
- Calendar Immunome, Inc.
